LfcinB (20–30)2
General Information
DRACP ID DRACP00790
Peptide Name LfcinB (20–30)2
Sequence RWQWRMKKLGRWQWRMKKLGKX
Sequence Length 22
UniProt ID Not available
PubChem CID Not available
Origin Bovine Lactoferricin
Type Native peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
MDA-MB-468 | Breast adenocarcinoma | Carcinoma | IC50=5 μM | MTT assay | 2h | 1 |
MDA-MB-231 | Breast adenocarcinoma | Carcinoma | IC50=14 μM | MTT assay | 2h | 1 |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antitumor; Antimicrobial
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification X=Ahx
Chiral L
Physicochemical Information
Formula C134H210N44O23S2
Absent amino acids ACDEFHINPSTVY
Common amino acids K
Mass 335429
Pl 13
Basic residues 9
Acidic residues 0
Hydrophobic residues 6
Net charge 9
Boman Index -7277
Hydrophobicity -170.45
Aliphatic Index 35.45
Half Life
/
Extinction Coefficient cystines 22000
Absorbance 280nm 1047.62
Polar residues 2
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 28961215
Title Antibacterial Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Cytotoxic Effect against MDA-MB-468 and MDA-MB-231 Breast Cancer Cell Lines
Year 2017
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available